164 related articles for article (PubMed ID: 32892682)
21. Pretreatment thrombocytosis predict poor prognosis in patients with endometrial carcinoma: a systematic review and meta-analysis.
Nie D; Yang E; Li Z
BMC Cancer; 2019 Jan; 19(1):73. PubMed ID: 30646853
[TBL] [Abstract][Full Text] [Related]
22. Prognostic role of indoleamine 2,3-dioxygenase 1 expression in solid tumors: A systematic review and meta-analysis.
Zhang H; Li J; Zhou Q
Front Oncol; 2022; 12():954495. PubMed ID: 36212460
[TBL] [Abstract][Full Text] [Related]
23. Prognostic value of TP53 concurrent mutations for EGFR- TKIs and ALK-TKIs based targeted therapy in advanced non-small cell lung cancer: a meta-analysis.
Qin K; Hou H; Liang Y; Zhang X
BMC Cancer; 2020 Apr; 20(1):328. PubMed ID: 32299384
[TBL] [Abstract][Full Text] [Related]
24. Prognostic value of TGF-β in lung cancer: systematic review and meta-analysis.
Li J; Shen C; Wang X; Lai Y; Zhou K; Li P; Liu L; Che G
BMC Cancer; 2019 Jul; 19(1):691. PubMed ID: 31307405
[TBL] [Abstract][Full Text] [Related]
25. Prognostic impact of geriatric nutritional risk index on patients with urological cancers: A meta-analysis.
Wu Q; Ye F
Front Oncol; 2022; 12():1077792. PubMed ID: 36713504
[TBL] [Abstract][Full Text] [Related]
26. Pretreatment elevated serum lactate dehydrogenase as a significant prognostic factor in malignant mesothelioma: A meta-analysis.
Zhuo Y; Lin L; Wei S; Zhang M
Medicine (Baltimore); 2016 Dec; 95(52):e5706. PubMed ID: 28033270
[TBL] [Abstract][Full Text] [Related]
27. The pretreatment thrombocytosis may predict prognosis of patients with colorectal cancer: a systematic review and meta-analysis.
Wang YH; Deng SJ; Yang YD; Yao N; Zhao JM; Min GT; Wang J; Xu TF; Zhao PY; Wang HP; Chen W
Biomark Med; 2017 Feb; 11(2):195-210. PubMed ID: 28097884
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of performance status in metastatic renal cell carcinoma patients receiving tyrosine kinase inhibitors: a systematic review and meta-analysis.
Xu Y; Zhang Y; Wang X; Kang J; Liu X
BMC Cancer; 2019 Feb; 19(1):168. PubMed ID: 30795756
[TBL] [Abstract][Full Text] [Related]
29. The prognostic role of pretreatment thrombocytosis in gastric cancer: A systematic review and meta-analysis.
Yang C; Jiang H; Huang S; Hong H; Huang X; Wang X; Liao W; Wang X; Chen X; Jiang L
Medicine (Baltimore); 2018 Aug; 97(31):e11763. PubMed ID: 30075601
[TBL] [Abstract][Full Text] [Related]
30. Poor Prognosis Significance of Pretreatment Thrombocytosis in Patients with Colorectal Cancer: a Meta-Analysis.
Zhao JM; Wang YH; Yao N; Wei KK; Jiang L; Hanif S; Wang ZX
Asian Pac J Cancer Prev; 2016; 17(9):4295-4300. PubMed ID: 27797233
[TBL] [Abstract][Full Text] [Related]
31. Blood transfusions may adversely affect survival outcomes of patients with lung cancer: a systematic review and meta-analysis.
Cho S; Park J; Lee M; Lee D; Choi H; Gim G; Kim L; Kang CY; Oh Y; Viveiros P; Vagia E; Oh MS; Cho GJ; Bharat A; Chae YK
Transl Lung Cancer Res; 2021 Apr; 10(4):1700-1710. PubMed ID: 34012786
[TBL] [Abstract][Full Text] [Related]
32. Prognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysis.
Zhang LQ; Wang J; Jiang F; Xu L; Liu FY; Yin R
PLoS One; 2012; 7(3):e34100. PubMed ID: 22457815
[TBL] [Abstract][Full Text] [Related]
33. Clinicopathological and prognostic significance of mTOR and phosphorylated mTOR expression in patients with esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Li S; Wang Z; Huang J; Cheng S; Du H; Che G; Peng Y
BMC Cancer; 2016 Nov; 16(1):877. PubMed ID: 27835987
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Value of Pretreatment D-Dimer Level in Small-Cell Lung Cancer: A Meta-Analysis.
Li J; Wang Y; Li J; Che G
Technol Cancer Res Treat; 2021; 20():1533033821989822. PubMed ID: 33563114
[TBL] [Abstract][Full Text] [Related]
35. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
Shao Y; Li W; Wang D; Wu B
World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of osteopontin in patients with lung cancer: a meta-analysis.
Peng B; Wang YH; Huang Z; Feng SJ; Wang YS
Int J Clin Exp Med; 2014; 7(12):4616-26. PubMed ID: 25663958
[TBL] [Abstract][Full Text] [Related]
37. Prognostic and Clinicopathological Value of Rac1 in Cancer Survival: Evidence from a Meta-Analysis.
Lou S; Wang P; Yang J; Ma J; Liu C; Zhou M
J Cancer; 2018; 9(14):2571-2579. PubMed ID: 30026856
[No Abstract] [Full Text] [Related]
38. The expression profile and clinic significance of the SIX family in non-small cell lung cancer.
Liu Q; Li A; Tian Y; Liu Y; Li T; Zhang C; Wu JD; Han X; Wu K
J Hematol Oncol; 2016 Nov; 9(1):119. PubMed ID: 27821176
[TBL] [Abstract][Full Text] [Related]
39. The prognostic value of epigenetic silencing of p16 gene in NSCLC patients: a systematic review and meta-analysis.
Lou-Qian Z; Rong Y; Ming L; Xin Y; Feng J; Lin X
PLoS One; 2013; 8(1):e54970. PubMed ID: 23372805
[TBL] [Abstract][Full Text] [Related]
40. Clinicopathological and prognostic significance of thyroid transcription factor-1 expression in small cell lung cancer: A systemic review and meta-analysis.
Wang Y; Wu Y; Li J; Li J; Che G
Pathol Res Pract; 2019 Dec; 215(12):152706. PubMed ID: 31704153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]